APA (7th ed.) Citation

KS, S., K, P., RS, F., I, D., S, B., P, N., . . . Å, H. (2026). Clinical outcomes of genomically guided trametinib monotherapy across cancer types: Results from the IMPRESS-Norway trial. Acta oncologica (Stockholm, Sweden), 65, 90. https://doi.org/10.2340/1651-226X.2026.45086

Chicago Style (17th ed.) Citation

KS, Slørdahl, et al. "Clinical Outcomes of Genomically Guided Trametinib Monotherapy Across Cancer Types: Results from the IMPRESS-Norway Trial." Acta Oncologica (Stockholm, Sweden) 65 (2026): 90. https://doi.org/10.2340/1651-226X.2026.45086.

MLA (9th ed.) Citation

KS, Slørdahl, et al. "Clinical Outcomes of Genomically Guided Trametinib Monotherapy Across Cancer Types: Results from the IMPRESS-Norway Trial." Acta Oncologica (Stockholm, Sweden), vol. 65, 2026, p. 90, https://doi.org/10.2340/1651-226X.2026.45086.